Filing Flows › Guardian Pharmacy Services (GRDN) › Q3 2026
Guardian Pharmacy Services (GRDN) Q3 2026 earnings results (third quarter 2026)
10-Q filed Nov 5, 2026
Guardian Pharmacy Services (GRDN) reported revenue of $371M for the third quarter 2026 (Q3 2026), -2% from a year earlier and +5% from the quarter before. Operating margin was 6.8%, net earnings $18.7M (5.0% of revenue).
Guardian Pharmacy Services, Q3 2026: revenue $371M (-2% year over year), operating margin 6.8%, net earnings $18.7M, operating cash flow $43.4M. The chart follows the revenue to costs, profit and cash.
| Q3 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $371M | +5% | -2% |
| Gross profit | $85.2M | +6% | +14% |
| Operating profit | $25.1M | +21% | +53% |
| Net earnings | $18.7M | -15% | +90% |
| Operating cash flow | $43.4M | +44% | +54% |
| Free cash flow | $39.3M | — | +71% |
What changed
Revenue was $371.1M in Q3 2026, down 2% year over year and up 5% from the previous quarter.
Gross margin was 23.0%, up 3.2 points from Q3 2025. Operating profit was $25.1M, a 6.8% margin (up 2.4 points year over year). Operating expenses grew 3% against a revenue fall of 2%. Net earnings were $18.7M, up 90% year over year. The effective tax rate was 26.4%.
Operating cash flow was $43.4M (up 54% year over year), 227% of net income including minority interests. Non-cash charges added back $5.9M of depreciation and amortization and $2.7M of share-based compensation. Working capital and other items added $15.6M. Capital expenditures of $4.0M left free cash flow of $39.3M.
Questions
What was Guardian Pharmacy Services' revenue in the third quarter 2026?
Guardian Pharmacy Services (GRDN) reported revenue of $371M for the third quarter 2026 (Q3 2026), -2% from a year earlier and +5% from the quarter before.
Was Guardian Pharmacy Services profitable in the third quarter 2026?
Operating profit was $25.1M (6.8% of revenue) and net earnings $18.7M.